We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Statins Help Lower Risk of Atherosclerosis by Reducing the Size of Arterial Plaques

By LabMedica International staff writers
Posted on 26 Dec 2011
Statins, a class of drugs that help reduce risk of atherosclerosis by lowering levels of low-density lipoproteins (LDL), also decrease the size of arterial plaques by stimulating macrophage emigration.

Investigators at New York University (NY, USA) worked with a novel mouse-transplant model of atherosclerosis regression in which aortic segments from diseased donors were placed into recipients with normal cholesterol levels. More...
With this model they had previously shown that the induction of a chemokine receptor CCR7(C-C chemokine receptor type 7)-dependent emigration process triggered the rapid loss of CD68+ cells (mainly macrophages) from arterial plaques.

In the current study, the investigators examined the effect of statins on macrophage emigration from plaques. They reported in the December 6, 2011, online edition the journal PLoS One that when mice that had been genetically engineered to lack the gene for apolipoprotein E were fed a western diet-fed while being treated with either atorvastatin or rosuvastatin they experienced a substantial reduction in the CD68+ cell content in the plaques despite continued hyperlipidemia. There was a significant increase in CCR7 mRNA in CD68+ cells from both atorvastatin and rosuvastatin treated mice associated with emigration of CD68+ cells from plaques. Mice that lacked both the gene for apolipoprotein E and the gene for CCR7 failed to display a reduction in CD68+ cell content upon statin treatment.

The results of this study indicate that statins, in addition to their traditionally considered effects on atherosclerosis by retarding plaque progression through lowering LDL-cholesterol, may also have additional clinical benefits by accelerating plaque regression through enhancing CCR7 expression and emigration of CD68+ macrophages. These beneficial effects would have been missed if changes in plaque size had been the sole criterion of success.

“Our experimental findings indicate that statins, in addition to lowering LDL cholesterol, have clinical benefits of accelerating plaque regression by a newly discovered mechanism,”said senior author Dr, Michael Garabedian, professor of microbiology and urology at New York University. “It is possible that these drugs could possibly be more beneficial to a wider population of patients potentially reducing the overall lifetime burden of plaque and the prevention of atherosclerosis.”

Related Links:

New York University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.